Study to Assess the Efficacy and Safety of PF-06651600 in Subjects with Rheumatoid Arthritis with an Inadequate Response to Methotrexate
A Phase 2a, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multi-Center Study to Assess the
Efficacy and Safety Profile of PF-06651600 in Subjects With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to Methotrexate
Category & Conditions: Immune System Diseases and Conditions
Medicine: PF-06651600
ClinicalTrials.gov Identifier (NCT): NCT02969044
Protocol ID: B7981006
PrintDownloadOpen Plain Language Summary Result: Click here